US EditionOregon to get share of $335 million opioid settlement with drugmaker Mylan
- Mylan Inc., a pharmaceutical company, reached a multistate settlement over opioid marketing practices.
- States investigated Mylan for deceptively marketing opioid products as less prone to abuse.
- The settlement involves 15 states and addresses Mylan's marketing of fentanyl patches, oxycodone, and buprenorphine.
- Attorney General Rayfield stated, "This settlement is not just a financial victory, it’s a reckoning."
- Mylan will pay up to $335 million to states over nine years, without admitting wrongdoing, to resolve claims.
30 Articles
30 Articles
Minnesota must act faster in combating the opioid crisis
Minnesota stands at a critical juncture in addressing the opioid crisis. With our state expecting $535 million from settlements with opioid manufacturers, distributors and pharmacy chains over the next 18 years, we have an unprecedented opportunity to build effective prevention and treatment programs.Yet reports indicate that many Minnesota cities and counties have gotten off to a slow start, spending just a portion of the more than $50 million …
Utah to receive millions through another opioid settlement • Utah News Dispatch
Utah Attorney General Derek Brown talks to reporters during his first press conference at the Utah State Capitol Building on Thursday, Jan. 9, 2025. (Kyle Dunphey/Utah News Dispatch) Utah will continue to see millions more in funds secured through litigation with companies that manufactured or sold opioids, after a new settlement was announced on Monday with the global pharmaceutical company Mylan Inc. According to the Utah Attorney General’s Of…
AG Weiser secures $5.5 million in opioid settlement
(COLORADO) — On Monday, April 7, Colorado Attorney General Phil Weiser announced that Colorado will receive more than $5 million in funds as part of a nationwide $335 million opioid settlement with pharmaceutical company Mylan Inc. According to a press release from Weiser's office, Mylan, which is now a part of Viatris, has manufactured and sold a variety of opioids since 2005, including generic fentanyl patches, oxycodone, hydrocodone, and bupr…
Coverage Details
Bias Distribution
- 55% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
